Accuracy of a Novel Glucose Monitoring System during Neurosurgical craniotomy

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100042493

Enrollment

Unknown

Registered

2021-01-22

Start date

2021-09-06

Completion date

Unknown

Last updated

2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Interventions

upper arm group:None

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years and <= 75 years; 2. ASA I~III grade; 3. Patients undergoing neurosurgical excision of epileptogenic focus under general anesthesia; 4. Patients who are willing to participate in this study and sign up the informed consent.

Exclusion criteria

Exclusion criteria: 1. Known allergy to medical grade adhesive used to prepare the skin; 2. Skin lesions, scarring, redness, infection, or edema at the sensor application sites; 3. The patient refused to be monitored by the blood glucose monitor.

Design outcomes

Primary

Measure	Time frame
Blood glucose;	—

Countries

China

Contacts

Public ContactWang Tianlong

Xuanwu Hospital, Capital Medical University

w_tl5595@hotmail.com+86 13910525304

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026